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The purpose of this investigation is to establish a 
method which will enable the physician to predict which 
individuals afflicted with primary hypertension are likely 
to die of renal failure with the belief that this knowledge 
will be of assistance not only in the classification of 
individuals with hypertension but also in the intelligent 
choice of therapy. The hypothesis is that primary hyper¬ 
tension destined to terminate in fatal uremia presents a 
clinical picture sufficiently distinct from primary hyper¬ 
tension terminating in other forms of death to be identified 
at the time the diagnosis of hypertension is first made. 
In order to test this hypothesis, it was first necessary 
to examine thoroughly the clinical and post-mortem records 
of a population which suffered from primary hypertension to 
determine which clinical criteria provided the best means of 
identifying those individuals who died of renal failure. A 
discriminant equation, the parameters of which represented 
the age, systolic blood pressure, heart size, and blood urea 
of each individual at the time the diagnosis of hypertension 
was initially made, was derived from one population and provec 
to be a good means of achieving this identification. It was 
essential, however, that the prognostic accuracy of this 
equation be assessed by applying it on a different population 
of individuals with primary hypertension, and this was done 





REVIEW OF THE LITERATURE 
I . Classification o f Hypertension: 
The classification of hypertension began well over 
a century ago when Bright first observed the occurrence of 
contracted kidneys and cardiac hypertrophy in patients with 
a clinical history of albuminuria and an elevated blood 
urea: 
I do not...by any means assert, that all the 
1 es i ons. . .f1ow as a consequence from the kid¬ 
neys alone; but that they are such derangements 
as generally co-exist with this peculiar dis¬ 
ease of that organ. ...(p. 395 ) 
...the chemical qualities of the blood are so 
far changed, that urea is to be detected in 
that fluid.. ..(p. 395 ) 
...either the altered quality of the blood 
affords irregular and unwonted stimulus to 
the organ [heart] ...or, that it so affects 
the minute and capillary circulation, as to 
render greater action necessary to force 
the blood through the distant sub-divisions 
of the vascular system, (pp. 396-7)^ 
Bright concluded that: 
...the hypertrophy of the heart seems, in 
some degree, to have kept pace with the 
advance of the disease in the kidneys.... 
the hardness and contraction of the kidney 
bespoke...of a long continuance of the 
disease...(p. 397) 
In the years following Bright's work, Gull and 
2 
Sutton4' broadened our knowledge of the pathologic changes 

3 
associated with hypertension by describing the vascular 
alterations seen in Bright's disease, while Mahomed, in 
1879, actually implicated high blood pressure as the 
etiological culprit: "high arterial pressure, and the 
subsequent cardio-vascular changes are the primary and 
most important conditions to recognize, while the kidney 
symptoms are only secondary.As Pickering^ notes, however, 
the concept that a form of hypertension might occur in¬ 
dependently of nephritis truly became well established with 
S ft 
the writings of HuchardJ and Allbutt0, among others. 
The current classification of hypertension has much 
of its foundation in the work of Volhard and Fahr who, in 
1914, divided renal disease into three categories: nephrosis; 
nephritides; and arteriosclerotic disease.^ They noted 
the association between pure sclerosis of the renal vessels 
and benigfe hypertension and also described a sclerotic kidney 
with necrotic changes compatible with the current concept of 
the kidney in malignant hypertension. It remained, though, 
O 
for Klemperer and Otani° to stress that the kidneys in this 
form of hypertension are generally not contracted, for Keith, 
9 10 
Wagener, and Kernohan, as well as Ellis, to emphasize the 
importance of papilledema in the diagnosis of this condition, 
and for Derow and Altschule^ to note that malignant hyper¬ 
tension might occur in a variable context: with no evidence 

4 
of previously existing hypertension; as the end stage of 
essential hypertension, with or without uremia; or as the end 
stage of a miscellaneous group of conditions which might cause 
secondary hypertension. 
Since the work of Volhard and Fahr, progress in the 
classification of hypertension has involved, for the most 
part, the discovery of other causes of secondary hypertension, 
which is defined as hypertension occurring as the manifest- 
4 
ation of a known disease. Nevertheless, despite the dis¬ 
covery of causes such as Cushing’s syndrome, renal artery 
stenosis, and primary aldosteronism, the vast majority of 
cases of hypertension remain of unknown etiology and, hence, 
are designated as primary, or essential, hypertension. 
II. Prognosis o f Hyp ertension : 
One of the earliest investigations into the prognosis 
12 
of hypertension was published in 1913 by Janeway who 
studied a population of patients, referred to him or his 
father, over a 9-year period. Janeway concluded that "the 
most prominent symptoms associated with high blood pressure 
are circulatory rather than renal" and that the disease 
underlying high arterial pressure was predominantly a dis¬ 
ease of the circulatory system "best designated hypertensive 
cardiovascular disease." 
A. Symp t oms: 
For Janeway, symptoms played a prominent 




He reported that among his population dyspnea indicated 
a greater than 50% probability of death by cardiac insuf¬ 
ficiency, while "anginoid" pain indicated about a one-third 
probability of death in an anginal paroxysm. Polyuria, 
especially nocturnal, and headache, particularly early morn¬ 
ing, each indicated about a 50% probability of a uremic 
death. One of the major difficulties, however, with Janeway's 
study was that essentially no autopsies were performed, and 
he, himself, notes that the incidence of uremic deaths is 
almost certainly too high, with apoplexy being the terminal 
event in many of these cases. Also, one is uncertain as to 
how many of his uremic deaths were secondary to nephritis 
rather than to primary hypertension with severe nephrosclerosis. 
In fact, with the possible exception of malignant hyper¬ 
tension, the development of which is frequently heralded by 
1314 9,13,14 
visual impairment ’ , and severe headaches, clinical 
symptoms alone have not generally been found to be very 
useful for the prognosis of hypertension. Thus, Rasmussen 
and B^e^ concluded that myocardial infarction and uremia 
were difficult to prognosticate in hypertension as they 
showed no distinct relation to earlier symptoms in the car¬ 
diovascular or renal systems, and Griep e t al^ felt that 
the most significant prognostic factor was the initial pre¬ 
sence of vascular disease as manifested by signs and laboratory 
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tests, rather than symptoms. Nevertheless, Sokolow and 
Perloff^ were able to demonstrate some correlation between 
symptoms such as headaches, nervous tension, and dizziness and 
overall mortality, though this was felt to be a factor of the 
associated vascular complications rather than of the symptoms 
alone. Further, their most impressive correlations were between 
signs and laboratory tests and overall mortality. 
B. Ophthalmologic Findings: 
As noted earlier, Keith, Wagener, and 
9 
Kernohan stressed the importance of papilledema in the 
diagnosis of the malignant form of hypertension. Somewhat 
1 8 
later, in 1939, Keith, Wagener, and Barker devised a 
classic system for grading the severity of essential hy¬ 
pertension based primarily on the findings on fundoscopic 
examination which ranged from minimal changes in retinal 
vessels through compression at arterio-venous junctions to 
severe sclerosis, hemorrhages, and plaques, and, finally, 
to edema of the discs. They were able to demonstrate four 
different survival curves, one for each grade of severity, 
and the validity of their prognostic system has been re- 
19 17 
affirmed by Simpson and Gilchrist , by Sokolow and Perloff 
2 0 
and, most recently, by Breslin e t a1 who showed that ten 
and twenty-year survival rates of patients with essential 
hypertension were both lower than those for the normal popu¬ 
lation at the same age and correlated well with the Keith- 

7 
Wagener-Barker ophthalmologic grouping. They also found 
this grouping to correlate well with the diastolic blood 
pressure of their hypertensive patients. 
C. Sex: 
Another extremely significant contribution to 
the prognosis of hypertension was the large study of Bechgaard, 
published in 1946, of over one thousand untreated patients 
with hypertension seen at a polyclinic in Copenhagen. The 
vast majority of these patients was in the fifth through 
the seventh decade of life and was followed initially for up 
to eleven years. Bechgaard demonstrated unquestionably that 
men tolerated elevations of blood pressure, both systolic 
and diastolic, less well than did women. The overall mortality 
for men was 41% compared to only 22% for women, and the pro¬ 
portion of men dying was greater than women in all age groups. 
Further, while the mortality for both sexes increased with el¬ 
evation of the blood pressure, men displayed a large increase 
in mortality at systolic pressures equal to or greater than 
200 mm Hg, but women displayed a similar increase only when 
systolic pressures equal to or greater than 220 mm Hg were 
reached. Men also displayed a very high mortality rate at 
diastolic pressures equal to or greater than 130 mm Hg in 
contrast to women who had a much lower mortality rate at 




men for elevated blood pressures is the reason why the mean 
blood pressure in old men is somewhat lower than in old 
22 
w ome n. 
This decreased male tolerance for elevated blood pres- 
1 2 
sures is also consistent with Janeway's finding of an 
average survival time after the onset of symptoms of only 
4 years for men and 5 years for women. Moreover, it is in 
agreement with a greater percentage of male than female 
deaths among hypertensive patients reported by investigators 
2 3 , 15 
such as Blackford e t a1 and Rasmussen and Bpe . This sex 
intolerance has more recently been confirmed by Breslin e t a 1 
who demonstrated that women survived longer than men in each 
ophthalmologic grade, though there is some evidence to suggest 
that the mortality rates for the sexes tend to equal each 
, . , 3 17,24,25 
other m the more severe grades. A general male 
intolerance to elevated blood pressure greater than the 
female intolerance has, of course, been reported by numerous 
other investigators^,^,^!^ since Bechgaard and may, in 
part, be attributable to the increased incidence of the 
, . „ , , , _ 9,13,17,28,29 
malignant phase of hypertension as well as 
,. . 30 
coronary artery disease m men. 
D. Age: 
4 
As Pickering notes, almost all investigators 
are agreed that essential hypertension is a disease of middle 
age or later. It would be expected, therefore, that hyper¬ 
20 
tension presenting at a relatively young age might have a 

9 
. 21,25,26 , . . 
poorer prognosis than hypertension appearing later 
in life for several reasons. First, hypertension in a 
young person has a relatively greater likelihood of being 
secondary hypertension with either primary renal disease 
or hormonal secreting tumors, for example, as the etiology. 
Also, one might expect that a young person presenting with 
symptoms referrable to hypertension already has a rather 
serious degree of systemic involvement. A third factor, 
however, which worsens the prognosis of hypertension 
appearing at an early age is that it might be malignant hyper¬ 
tension which has an earlier age of onset than does benign 
hypertension, a fact reported by virtually every investigator 
in this field. 
8,9,10,13,18,21,28,31 
An additional explanation 
2 1 
for findings such as Bechgaard's that while the excess 
mortality rate for patients with hypertension, compared to 
the Dutch population as a whole, was 143% for women and 288% 
for men, the mortality was highest in the younger age groups 
and diminished with advancing age is Pickering 1s ^ suggestion 
that this is a consequence of the tendency for arterial pres¬ 
sure to increase with age in the population at large. 
E . Height o f Blood Pressure: 
12 
Janeway “ concluded that systolic blood 
pressures above 160 mm Hg were always pathological, though he 
suspected that some day 150 mm Hg would be considered the 

10 
upper limit of normal. Nonetheless, the relationship be¬ 
tween the height of the blood pressure and the prognosis 
remained doubtful to him though, in his population, a 
systolic pressure well above 200mm Hg tended to augur death 
, 15 
from uremia or apoplexy. Rasmussen and Boe, recording 
pressures obtained after eight to fourteen days of rest, 
found that nearly one-third of their patients with systolic 
pressures greater than 200mm Hg and more than one-third with 
diastolic pressures greater than 125mm Hg died of apoplexy. 
Bechgaard, reported an increase in the overall mortality 
rate with elevations of both the systolic and diastolic 
blood pressure, with the aforementioned sexual differences, 
2 7 
and Leishman concluded that an elevated diastolic pressure 
was an unfavorable prognostic sign. Also, Sokolow and Perloffl? 
demonstrated an increase in mortality rate with increasing 
levels of both systolic and diastolic blood pressure, though 
Griep e_t al} ^ felt that an elevated blood pressure, per s e , 
without evidence of hypertensive complications, had little effect 
on the prognosis. The latter group of investigators were also 
unable to correlate elevations of blood pressure with apoplexy. 
In general, then, it is fair to say that severe elevation of 
blood pressure is associated with decreased survival time but 
has a questionable relationship to the actual cause of death. 

Cardiac and Renal Status: F . 
1. Cardiac Enlargement and Left Ventricular 
Hypertrophy: The estimation of the prognosis of hypertension 
on the basis of clinical signs and laboratory findings per¬ 
taining to cardiac and renal status has, in general, been more 
fruitful than has the application of clinical symptoms, such 
1 2 
as dyspnea or polyuria, for this purpose. Thus, Janeway 
noted that a very high percentage of his deceased patients 
had evidence of cardiac enlargement on physical examination, 
and Rasmussen and Bfie'*'^ found that mortality, especially 
from cardiac insufficiency and to a lesser extent from 
myocardial infarction, rose considerably with increased 
heart size, as demonstrated by roentgenology. Mortality rates 
from cardiac insufficiency also seemed related to the degree 
of left ventricular hypertrophy, by electrocardiographic 
2 1 
criteria, in their study. Bechgaard employed roentgeno1ogic 
evaluation of cardiac size and electrocardiographic evidence 
of cardiac damage in a very general manner in estimating 
16 
prognosis in his study. Griep e t a 1 found a higher mortality 
among patients with roentgenologic evidence of cardiac 
enlargement and among patients with either left axis deviation 
or T-wave inversions on the electrocardiogram but was unable 
to correlate these findings with any particular cause of 
death. Leishman, however, concluded that strain patterns 




prognosis. Simpson and Gilchrist reported that T-wave 
abnormalities indicated a worse prognosis. 
One of the best studies of the effect of cardiac 
status on the prognosis of hypertension, however, was that 
of Sokolow and Perloff.^ They placed cardiac enlarge¬ 
ment, on the basis of roentgenology, into four grades 
according to the percent enlargement and found the differ¬ 
ence in mortality between successive grades of enlargement 
to be highly significant (p<0.001), with a greater mortal¬ 
ity for men than women only in the first grade of enlargement. 
There was no significant sex difference in mortality rates 
for the higher grades of enlargement though the mortality 
rate for both sexes increased with each grade of enlargement. 
Electrocardiographic evidence of left ventricular hypertrophy 
was also placed into four grades of increasing severity 
with significant differences in mortality rates observed 
between the normal electrocardiogram and grades I and II, 
combined, and grades III and IV, combined. Again, lower 
mortality rates for women were observed only for the mildest 
degrees of hypertrophy. These investigators did not cor¬ 
relate a particular cause of death with cardiac status alone, 
h owe ve r. 
2. Abnormal Renal Function: Abnormal renal 
function is generally considered to be an ominous sign in the 
prognosis of hypertension since it may herald the arrival 

13 
of malignant hypertension, may represent primary renal disease, 
or may bespeak the severity of nephrosclerosis or the presence 
of cardiac failure. Several investigators^ > ^ > 32 have doc¬ 
umented the almost universal presence of persistent or moder¬ 
ate proteinuria with malignant hypertension. Rasmussen and 
Btie^^ reported that those patients with persistent protein¬ 
uria showed a considerably increased mortality rate, especially 
from apoplexy and cardiac insufficiency, while those with 
only transient proteinuria and those without proteinuria had 
virtudly identical mortality rates. Interestingly, though, 
they found no significant increase in mortality rate for 
2 7 
those patients with a decrease in urea clearance. Leishman 
found that persistent and/or moderate proteinuria fore¬ 
shadowed death from uremia or cerebrovascular accident, 
16 19 
and Griep e t a 1 and Simpson and Gilchrist concluded that 
proteinuria was an ominous sign. The latter group also 
demonstrated that a decrease in the urine urea concentration 
indicated a poor prognosis for women, while Sokolow and 
Perloff found that impaired renal function secondary to 
arteriolar disease was associated with a very high mortality 
rate . 
G. Multiple P ar ame t e r s: 
In an attempt to improve the accuracy of 
prognosis in hypertension, some investigators have employed 
systems in which patients are grouped into different categories 

14 
on the basis of the severity of involvement of more than one 
organ system. Thus, Palmer et al grouped patients into 
four categories according to clinically recognizable changes 
in the fundi, heart, and kidneys, with placement determined 
by the most severe changes whether in one or more systems. 
They found that the mortality rose significantly with the 
different categories of severity over an eight-year period. 
More recently, Sokolow and Perloff^ employed degrees 
of elevation of both systolic and diastolic pressure, fundal 
changes, electrocardiographic changes, and cardiac enlarge¬ 
ment, as evidenced by roentgenologic examination, with the 
most severe degree of involvement in any system determining 
the ultimate grade, to classify their patients for the purpose 
of prognosis. A progressive rise in 5-year mortality was 
observed between each successive grade of severity. The only 
association between grade of severity and cause of death, 
however, was that those patients in the two lowest grades of 
severity seemed more prone to "atherosclerotic" causes of 
death, by which term they were evidently referring to lesions 
such as coronary thrombosis, cerebrovascular accident, and 
dissecting aneurysm, as well as to non-cardiovascu1 ar causes 
of death. Those patients in the two highest grades of severity 
seemed prone to both "atherosclerotic" and "hypertensive-re¬ 
lated" causes of death. The latter term evidently referred 
to conditions such as uremia, cardiac failure, and malignant 

15 
hypertension. Unfortunately, the precise definition of 
terms is unclear. Also, most of their information regarding 
causes of death was derived from death certificates and re¬ 
ports from physicians, casting the validity of some of their 
conclusions in this area into doubt. 
H . T re atmen t : 
One of the finest studies of the effect of 
medical treatment on the prognosis of hypertension is that 
of Smirk-^3 who discovered that the 5-year mortality among 
adequately treated hypertensive patients with either grade 
I or II (Keith-Wagener-Barker) fundal changes was reduced 
considerably below that of hypertensive patients with either 
comparable or milder degrees of involvement who remained 
untreated. Further, the degree of reduction in the mortality 
was greater when the basal blood pressure was high than 
when it was only moderately elevated. Another study attest¬ 
ing to the efficacy of treatment in improving the prognosis 
2 7 
of hypertension is that of Leishman who found that in be¬ 
nign hypertension the mortality rate among treated patients 
was in no instance appreciably more than one-third that of 
the untreated cases. 
Treatment has also been found to alter the relative 
o n 
frequency of the causes of death in hypertension. Leishman 
reported a notable decrease in death due to cerebrovascular 

16 
accident and uremia in treated patients compared to his 
control group, though the average duration of therapy for 
the group receiving medical treatment was only 3 years and 
34 
9 months. Hood e t a 1 reported that congestive failure as 
a cause of death dropped to an insignificant position among 
treated patients while the case fatality rate from myocardial 
infarction and cerebrovascular accident remained essentially 
unchanged. Finally, Smirk and Hodge J reported a very sharp 
decline in mortality from congestive heart failure and al¬ 
most a three-fold increase in mortality from coronary artery 
disease and sudden cardiac death in their treated group of 
hypertensive patients compared to their untreated group. 
Also, death from cerebrovascular accident showed a modest 
decline among the treated patients. Interestingly, the 
mortality from uremia showed a slight decline in the group 
under treatment from 1959 to 1961 compared to the control 
group (1950-1958). When the data for the treated group from 
1950 to 1958 are analyzed, however, the mortality from uremia 
is actually increased compared to the control group for the 
same years. Since the group of treated patients from 1959 
to 1961 included several hundred patients who were also in 
the treated group from 1950 to 1958,it is possible that the 
mortality from uremia is lower in this later group because 




In all of these studies, especially that of Smirk and 
Hodge, the percentage of deceased patients actually coming 
to autopsy was relatively low which creates certain difficul¬ 
ties in interpreting the results of these studies. For 
example, while it is true that a necropsy properly done pro¬ 
vides a catalogue of the diseases with which a person dies 
rather than an indictment of the actual cause of death, it 
is often extremely difficult to determine, solely from 
clinical evidence, whether or not a uremic death has been 
hastened by a cerebrovascular accident. It is also rather 
difficult, at times, to determine whether or not severe 
cardiac failure is the result of myocardial infarction or 
results solely from the effects of prolonged or severe hyper¬ 
tension. In general, however, the consensus seems to be that 
medical treatment not only has increased the survival time 
of patients with hypertension but also has lowered the pro¬ 
portion of deaths due to congestive heart failure. It has 
either increased or left unchanged the proportion of deaths 
due to coronary artery disease. 
I . Race: 
Finally, some comments are in order con¬ 
cerning the relationship between the Negro and hypertension. 
It is a fairly well established fact that Negroes in the 
United States have higher blood pressures, both systolic and 

18 
diastolic, than do whites.36,37,38 It has also been established 
that the prevalence of hypertension is twice as great in the 
Negro as the white population and that the likelihood of 
finding hypertensive heart disease associated with definite 
39 
hypertension is greater for Negro than for white persons. 
Also, the Negro death rate from hypertension, with or without 
mention of heart disease, is higher than it is for whites for 






I . De rivation o f Discriminant Equation: 
A. Selection o f Populat ion: 
1. Comp aris on Group: 
Postmortem records from the University of 
Virginia Hospital of 250 patients dying consecutively in the 
years 1960 through 1967 who had the clinical diagnosis of 
primary hypertension, defined as a persistent elevation of 
the systemic blood pressure without evident cause^ and 
without papilledema, attached to their necropsy reports 
were carefully studied. Each record was examined for in¬ 
formation concerning the age at death, cause of death, the 
weight and appearance of the kidneys and the heart (includ¬ 
ing the proximal 2 cm. of the ascending aorta), and the left 
ventricular thickness. Review of these records revealed that 
7 patients had lesions suggestive of inflammatory kidney 
diseases (e.g. pyelonephritis or glomerulonephritis). Since 
it was felt that these diseases represented clinically 
diagnosable causes of secondary hypertension, all 7 patients 
were removed from the study, leaving 243 patients (see Table 1). 
Further, none of these remaining patients had evidence of 

20 
fibrinoid necrosis on renal section. 
Of the 243 remaining patients, the clinical records of 
85 patients were either lost or incomplete to the extent 
that it was impossible to verify the diagnosis of hyperten¬ 
sion.These 85 patients were, therefore, removed from the study, 
leaving 158 patients, 20 of whom died of renal failure. The 
138 patients with primary hypertension who died of other 
causes form the comparison group for this study (see Table 1). 
2 . Case Group: 
The postmortem records of an additional 20 
patients dying consecutively in the years 1960 through 1967 
who had only the clinical diagnosis of uremia, not primary 
hypertension or any other renal disease, attached to their 
necropsy reports were also carefully studied in the manner 
described above. None of these 20 patients had lesions sug¬ 
gestive of inflammatory kidney disease or of any other causes 
of secondary hypertension or renal failure on review of these 
records, nor was there any evidence of fibrinoid necrosis. 
Review of their clinical records revealed that 16 of these 
20 patients had a history of hypertension without papilledema. 
These 16 patients were combined with the 20 patients dying 
of renal failure described above to form the case group of 
36 patients with primary hypertension who died of renal failure 
(see Table 1). 
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B . Clinical Observations: 
Clinical histories taken at the time when the 
diagnosis of hypertension was made at the University of 
Virginia Hospital were carefully examined for information 
concerning systemic blood pressure, heart size, blood urea, 
and blood creatinine levels, body bulk, and age. Age, 
when recorded, represented the age of only those patients 
who had no known previous history of hypertension prior to 
evaluation at this hospital. It was, therefore, the 
patient's age when his hypertension was initially discovered. 
This age is referred to in this study as the age at onset. 
Hypertension was considered present when a diastolic 
pressure equal to or greater than 90 mm Hg was recorded on 
at least two occasions or a diastolic blood pressure equal 
to or greater than 95 mm Hg was recorded on one occasion. 
Multiple readings, when recorded at the time of diagnosis, 
were averaged.Heights and weights were used as a basis for 
calculating the ponderal index (height in inches/cube root 
of weight in pounds). Blood urea and blood creatinine were 
41 42 
determined by the methods of Skeggs and Chasson e t a 1, 
respectively. Cardiac-thoracic ratio (widest transverse 
diameter of the heart/widest transverse diameter of the 
thoracic cavity taken just above the level of the dome of 

the diaphragm), a fair estimate of heart size, was measured 
only from large upright chest films taken during full in¬ 
spiration. 
It should be noted that virtually all the patients 
in this study, both those dying of renal failure and those 
dying of other causes, received various forms of medical ther 
apy , often quite vigorous, for their hypertension. Treat¬ 
ment was, of course, prescribed on an individual basis and 
ranged from dietary control, salt restriction, and mild se¬ 
dation to the use of diuretics, Rauwolfia alkaloids, and 
ganglionic-blocking drugs. Specific antihypertensive medi¬ 
cation was administered to the great majority of the patients 
with only a few patients being treated solely by dietary 
control and salt restrictions. 
C. Discriminant an d Regression An a 1y sis: 
For all the variables measured, means and standard 
deviations were calculated. The significance of differences 
between means was tested by the student’s t-test. An analysi 
of the clinical variables collected on the 2 groups was per¬ 
formed to determine which combination of clinical variables 
best separated those patients dying from renal failure from 
those dying of other causes, leading to the development of 
43 
a discriminant equation which described the manner in which 
44 
this separation was achieved. Simple regression analyses 
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were calculated using heart weight and kidney weight respect¬ 
ively as dependent variables and several clinical variables 
as independent variables to determine which of these clinical 
variables were the most effective predictors of cardiomegaly 
and renal atrophy. Since the techniques of both discriminant 
and regression analysis require that all the data on each var¬ 
iable be present, cases with any missing observations were 
discarded for that particular analysis. The numbers of pat¬ 
ients actually used in the analyses are indicated in the 
appropriate tables. The occurrence of missing data in the 
patients’ charts had no obvious pattern, so it is hoped that 
the omission of patients with incomplete data in these analy¬ 
ses will not introduce any bias. 
II. Application of Pis cr iminant Equation t o a_ Se cond 
Population: 
A. Selection o f Population: 
1. C omp a ris on Group: 
Subsequent to the derivation of a discrimin¬ 
ant equation based on the population at the University of 
Virginia Hospital, an attempt was made to apply this equation 
to the clinical variables derived from a different population 
of patients, all of whom suffered from primary hypertension, 
in order to determine how accurately it would predict those 
patients destined to die of renal failure and those destined 
to die of other causes. 

The clinical records of 300 patients consecutively 
admitted to, dying in, and autopsied at the Yale-New Haven 
Hospital from 1956 to 1966 who had a clinical diagnosis of 
primary hypertension were carefully examined to determine 
which patients actually had the diagnosis of hypertension 
made for the first time at this hoepital, or were referred 
to it untreated within 2 weeks after their own physician 
initially made this diagnosis. Only 52 patients actually 
satisfied this criterion (see Table 2). The other 248 
patients had a history of hypertension prior to evaluation 
at this hospital and, because this made them incomparable 
with the series from the University of Virginia Hospital, 
they were excluded from the study. The hospital records were 
carefully reviewed for these remaining 52 patients for 
information regarding cardiac-thoracic ratio, blood urea level, 
systolic pressure, and age all at the time the diagnosis of 
hypertension was initially made. 
Of these 52 patients, chest x-rays were not available 
for 12 patients and not taken for another 6 patients at the 
time the diagnosis was made. Of the remaining 34 patients, 
6 did not have blood drawn for urea estimation at the time 
the diagnosis was made, and autopsy reports were not avail¬ 
able for another 4 patients. 
Postmortem records of each of the 24 remaining patients 
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were carefully studied with the intention of excluding any 
patients with evidence of inflammatory kidney disease, any 
other lesion capable of causing secondary hypertension, or 
fibrinoid necrosis. No such evidence was found for any of 
these 24 patients. Further, none had a clinical history 
of p api1ledema. 
Of these 24 patients, 5 died of renal failure. The 
remaining 19 patients with primary hypertension first diagnosed 
at this hospital and with all of the above mentioned clinical 
data recorded at the time of the diagnosis died of other 
causes and form the comparison group for application of the 
discriminant equation, (see Table 2) 
2. Case Group: 
The clinical records of 58 patients consecu¬ 
tively admitted to, dying in, and autopsied at the Yale-New 
Haven Hospital from 1956 to 1966 who had a clinical diagnosis 
of uremia but who had no mention of the diagnosis of hyper¬ 
tension on the headsheet of their hospital chart were also 
carefully studied to determine which of these patients fit 
all of the previously mentioned criteria for the comparison 
group, save that they died of renal failure. Of these 58 pat¬ 
ients, 14 had no previous history of hypertension while 36 
had either a history of hypertension prior to evaluation 
at this hospital or a clinical history of inflammatory renal 
disease. The remaining 8 patients had a clinical history of 
hypertension which was first evaluated at this hospital and 

had no clinical history of either inflammatory renal disease 
or papilledema. Chest x-rays taken at the time hypertension 
was initially discovered were obtained for 6 of these 8 pat¬ 
ients. The films of 2 patients were unavailable, as were the 
autopsy reports of 2 other patients. The remaining 4 patient 
had all of the clinical variables which were recorded for 
the comparison group available, and all were recorded at the 
time hypertension was first discovered. 
The postmortem records of each of these 4 patients 
were then carefully studied for further evidence of inflam¬ 
matory renal disease, causes of secondary hypertension, and 
fibrinoid necrosis. No such evidence was found. These 4 
patients were combined, therefore, with the 5 patients who 
died of renal failure mentioned under the selection of the 
comparison group. These 9 patients, all of whom had primary 
hypertension first discovered at this hospital, had all of 
the pertinent data recorded at the time this hypertension was 
discovered, and died of renal failure, form the case group 
for application of the discriminant equation, (see Table 2) 
B. Clinical Observations: 
As previously noted, information regarding systolic 
blood pressure, blood urea level, cardiac-thoracic ratio, and 
age, all recorded at the time hypertension was initially dis¬ 
covered in each of the 19 patients in the comparison group 
and the 9 patients in the case group, was obtained for each 
of the 28 patients. The same criteria for defining hyper- 

tension in the study performed at the University of Virginia 
Hospital were employed in this study, as well. Multiple read 
ings at the time the hypertension was discovered, when record 
ed, were averaged, and the cardiac-thoracic ratio was derived 
in the manner previously described. Prior to April, 1959, 
the non-protein nitrogen level was measured at the Yale- 
New Haven Hospital.^ This value was converted to the blood 
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urea by multiplying it by a factor of 0.9. After April, 
4 7 
1959, the blood urea nitrogen level was measured, and this 
value was converted to the blood urea by multiplying it by 
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a factor of 2.1. Means and standard deviations were cal¬ 
culated for each of the clinical variables. 
C. Application o f the Discriminant F un c tion Equation: 
The systolic blood pressure, age, blood urea, and 
cardiac-thoracic ratio, all at the time the diagnosis of 
hypertension was initially made, were then entered into the 
discriminant equation derived from the population at the 
University of Virginia Hospital for each of the 28 patients 
in the population at the Yale-New Haven Hospital. A discrimi 
nant score for each patient was then calculated, and its 
effectiveness in predicting those patients who were to die 






I. Derivation o f Discriminant Equation - University of 
Virginia Hos pit a 1: 
A. Population: 
The entire population in the study performed at 
the University of Virginia Hospital consisted of 174 patients, 
all of whom suffered from primary lypertension . Classification 
by race and sex is found in Table 3. Negroes, both male and 
female, constituted the largest segment of the 36 patients 
who died of renal failure (72.2%), while white females com¬ 
prised the smallest segment of those dying of renal failure 
(8.3%). Among those patients who died of other causes, there 
was a slight predominance of whites (53.6%), though white 
females again constituted the smallest segment(18.8%). 
B . Causes o f Death: 
The causes of death in the comparison group are 
listed in Table 4. The major cause of death in this group 
was cerebrovascular accident (73). Fifty-three patients died 
of cerebral hemorrhage and 20 succumbed to cerebral infarction. 
Only a slightly greater proportion of Negro than white deaths 
were associated with a cerebrovascular accident. Myocardial 
infarction was the second most common cause, accounting for 
29 deaths, 20 of which were of white patients. Congestive 
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heart failure and very severe diabetes mellitus (with gan¬ 
grene and sepsis,or ketoacidosis) each accounted for 16 
deaths, though 13 other patients had mild diabetes; aortic 
aneurysms were responsible for 13 deaths. Interestingly, 
11 of these 13 deaths were of white patients. Chief among 
the other causes of death were pulmonary emboli (4), 
septicemia (3), cardiac arrhythmia (3), and mesenteric 
artery thrombosis (2). In addition to these, 12 other causes 
of death were discovered and are listed in Table 4. In 
several cases, multiple causes of death were listed for 
patients in this comparison group. 
Renal failure was unquestionably the cause of death 
in each of the 36 patients in the case group. In several 
cases, however, other conditions were associated with death 
from renal failure, and these are listed in Table 5. The 
most commonly associated conditions, especially among Negroes, 
were congestive heart failure and diabetes mellitus. None¬ 
theless , in each case congestive heart failure developed sub¬ 
sequent to the onset of uremia; none of the patients in 
the case group with diabetes mellitus had evidence of Kimmel- 
stiel-Wilson lesions on renal section. 
C. Pathologic Data: 
Examination of the pathologic data for those patients 
dying of renal failure revealed striking and significant dif- 
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ferences with regard to age at death, heart weight, and 
kidney weight when compared to the comparison group (see 
Table 6). Those persons dying of renal failure died 10 
years younger than did those dying of other causes. The 
mean age at death for the renal failure group was 52 years, 
while for the comparison group it was 62 years (t=4.35, 
p<f0.001). An analysis of the age at death according to 
decades for both groups is presented in Table 7. While the 
youngest age at death was in the comparison group, 24 
years old compared to 31 years old in the case group, 27 
patients (75%) of the case group had died of renal failure 
by the age of 59 contrasted to only 60 patients (43%) of 
the comparison group who had died of other causes by this 
age. The oldest age at death in the case group was 72 (2 
persons), while in the comparison group one patient lived to 
90 and 7 died in the ninth decade. 
While both groups demonstrated substantial cardiac 
hypertrophy (the mean heart weight of the entire population 
was 524 Grams), those dying of renal failure had a much greater 
degree of hypertrophy (see Table 6). The mean heart weight 
of the renal failure group was 607 Grams, while of the com¬ 
parison group it was 503 Grams (t= 3.96, p^O.001). The 
lightest heart in the renal failure group weighed 350 Grams 
compared to 275 Grams among those patients dying of other 
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causes. Further, while 79% of those dying of renal failure 
had hearts weighing 500 Grams or more, only 51% of the com¬ 
parison group had hearts weighing 500 Grams or more (see Table 
8). The heaviest heart in each group weighed 900 Grams. 
The last substantial difference between these 2 groups 
was the weight of the kidneys which averaged 112 Grams for 
the renal failure group and 150 Grams for those dying of 
other causes (t- 4.24, p«d 0.001; see Table 6). The kidneys 
of those patients dying of renal failure were generally 
contracted and shrunken grossly with a granular appearance. 
Microscopic examination revealed evidence of arteriolar 
nephrosclerosis in all cases, but in none was there evidence 
of fibrinoid necrosis. 
The thickness of the left ventricle was also measured 
in both groups. The mean was 19mm for the renal group and 
17 mm for the comparison group. Because of the possibility 
of slight inconsistencies in measurement, however, it was 
felt that not too much importance could be attached to this 
difference. 
D. Clinical Data: 
An examination of the clinical variables (see 
Table 9) also reveals important differences, especially with 
regard to the age at onset, initial systolic blood pressure, 
initial cardiac-thoracic ratio, and initial blood urea level 
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between the group dying of renal failure and the group 
dying of other causes. An analysis of some of these clinical 
variables within the entire population, according to race 
and sex, is also provided in Table 10. 
The mean age at onset of hypertension, that is, when 
the diagnosis was first made, was 46 years for the renal fail¬ 
ure group and 54 years for the comparison group (t= 3.20, 
p -CO.001). Of the renal failure group, 54% had the diagnosis 
of hypertension first made prior to age 50 as contrasted to 
only 34% of the comparison group (see Table 7). The youngest 
age at which the diagnosis was made was 26 years among those 
dying of renal failure; the oldest age was 63 years. Among 
those dying of other causes, the youngest age at which the 
diagnosis was made was 23 years; the oldest was 84 years. 
The mean initial systolic blood pressure for 
the renal failure group was 212 mm Hg, while for the compari¬ 
son group dying of other causes it was 190 mm Hg(t= 2.80, 
p<T 0.003) . White patients dying of renal failure had a some¬ 
what higher mean initial systolic blood pressure (223 mm Hg) 
than did Negroes (208 mm Hg), though in the group dying of 
other causes the mean values of the 2 racial groups were 
virtually identical. Also, the mean initial systolic blood 
pressures of white and Negro patients in the entire population 
were virtually identical, though females, as a whole, had a 
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somewhat higher mean value than did males (see Table 10). 
The mean initial cardiac-thoracic ratio was 58% for 
the renal failure group but only 53% for the comparison group 
(t= 2.51, p<0.008). Negroes, in both the case and compari¬ 
son groups had a greater mean value for this variable than 
did whites. In the entire population, females had a greater 
mean initial cardiac-thoracic ratio than did males (see 
Table 10). 
The mean initial blood urea for the renal failure 
group was 135 mg/100 ml, while for the comparison group it 
was 4 5 mg/100 ml (t= 5.95, p .u< 0.001). White patients had a 
higher mean initial blood urea than did Negroes in the renal 
failure group, though in the comparison group the difference 
was quite small. Also, the mean initial blood urea was 
higher for males than for females (see Table 10). The mean 
of the highest recorded blood urea in each patient at any 
time since the initial diagnosis of hypertension and the 
mean of the last recorded blood urea were 489 mg/100 ml and 
465 mg/100 ml, respectively, for the renal failure group, 
as contrasted to 94 mg/100 ml and 72 mg/100 ml, respectively, 
for the group dying of other causes. 
Blood creatinine was also recorded, but the number of 
people with this information was much smaller in the comparison 
group since this test was generally performed only when renal 
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malfunction was suspected. Ponderal indices were calculated 
whenever both height and weight were recorded in the charts, 
but no substantial difference between the two groups was 
observed (see Table 9). 
There was also no substantial difference between the 
mean initial diastolic blood pressure of the renal failure 
group, which was 119 mm Hg, and the comparison group, which 
was 113 mm Hg. This statement holds true when both these 
groups were separated by race, as well (see Table 9). 
Further, there was no difference between the sexes in the 
population as a whole for this value (see Table 10). 
Finally, duration of the illness from the time the 
diagnosis of hypertension was first made was calculated. It 
was shown that the renal failure group, though at a younger 
mean age at the time of diagnosis, lived for an average of 
only 5.0 years after the diagnosis was made, while, on average, 
the comparison group succumbed 7.5 years (t= 2.07, p<0.03) 
after the diagnosis. Interestingly, white patients who died 
of renal failure survived for an average of only 2.3 years, 
while Negro patients survived for 5.8 years. Among the 
comparison group, however, the average duration after the 
time of diagnosis of hypertension for white and Negro patients 
was essentially identical, 7.4 and 7.6 years, respectively 
(see Table 9). Also, in the population as a whole males and 
females had essentially identical average durations of 
7.0 and 6.8 years, respectively. 
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E. Derivation o f Pis criminant Equation f rom Clinical 
Data: 
No single clinical variable clearly separated 
those who died of renal failure from the rest of the 
population. For example, although the blood urea was 
much higher in the renal failure group, it was also quite 
elevated in many of the patients in the comparison group. 
Since many of the variables are intercorre1 ated, the impact 
of all the variables taken together is difficult to assess. 
Discriminant analyses using several different combinations 
of the clinical variables were, therefore, performed on those 
patients on whom complete data was available to determine 
whether the 2 groups could be more clearly differentiated 
on the basis of optimally weighting the clinical variables 
obtained at the time the diagnosis was first made. 
In discriminant analysis a single score is given to 
each patient and this score is a measure, in terms of the 
factors studied (the clinical variables in this instance), 
of the likelihood that a given patient will die of renal 
failure rather than of some other cause. The different 
factors are weighted in such a manner as to produce as small 
a range of scores as possible within each of the 2 groups and 
as little overlap as possible between the 2 groups. The 
efficiency of the discriminant score for selecting those who 
will die of renal failure from those who will die of other 
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causes diminishes, therefore, the more the scores for the 
2 groups overlap.^ The best discriminant analysis is shown 
in Table 11. Although only 49 cases (14 from the group dying 
of renal failure and 35 from the group dying of other causes) 
with complete data for all of the variables used in this 
analysis were available, the results were highly significant. 
Each of the 4 clinical variables (initial blood urea, 
age at onset, initial cardiac-thoracic ratio, and initial 
systolic blood pressure) contributed in varying degree to the 
differentiation of the renal failure group from the comparison 
group, but it can be seen that the greatest discrimination 
was made by the blood urea. The F ratio for the discriminant 
function was 12.02 (p<C0.001), indicating the differences 
in the discriminant scores could hardly have occurred by chance. 
This discriminant equation was then applied to the 
original data for the purpose of determining how well it 
could actually discriminate the renal from the comparison 
group. As is the usual custom, the discriminant co-efficients 
(see Table 11) were multiplied by a constant (in this case, 
1000) to avoid using cumbersome decimals, and the simplified 
equation actually employed was: 
D= -1.5 (age at onset) + 3 (initial cardiac-thoracic 
ratio) + 0.5 (initial systolic blood pressure) 
+ 1 (initial blood urea) 
Note that age at onset has a negative coefficient since 

older people tended to die of other causes. The other three 
variables have positive coefficients since they tended to 
favor death from renal failure. The coefficients, then, are 
essentially an optimal mathematical estimate of how much 
each piece of initial clinical information should be weighed, 
and the advantage of using a discriminant score is that 
several clinical variables and their complex interrelations 
are reduced to a single number. 
The discriminant scores for the renal failure group 
ranged from 221 to 471 ( mean, 325; S.D. = 75.6), while the 
comparison group scores ranged from 134 to 287 (mean, 216; 
S.D. = 32.1). Thus, in these patients if the score was less 
than 221, the patient was certain to die of other causes, and 
if the score was greater than 287, the patient was certain 
to die of renal failure. 
With scores in the range of 221 to 287, a definite prog¬ 
nosis could not be made, but the clinician could clearly in¬ 
dicate the uncertainty of his prediction. At a score of 230, 
one-third of the patients would die of causes other than 
renal failure, while at a score of 250 this would be true of 
only 14%, and at a score of 275 of only 3%. The minimum mis- 
classification was at a cutoff point of 249, where 15% of thos 
patients with scores above 249 died of other causes, and 15% 
with scores below 249 died of renal failure. (This point is 
usually obtained by bisecting the Mahalanobis distance 

between populations,^ but in this case, since the variances 
of the 2 groups were different, the point was obtained by 
working directly with the standard deviations of the 2 groups) 
F. Regression Analysis: 
Regression analysis was also performed, using the 
initial systolic and diastolic blood pressure, systemic 
pulse pressure, mean arterial pressure, blood urea, cardiac- 
thoracic ratio, and the duration of the hypertension from the 
time of the initial diagnosis in attempts to predict the 
final kidney weights and heart weights. The best fit for a 
single independent variable was found to be an inverse rela¬ 
tion between the initial systolic blood pressure and the 
mean kidney weight at autopsy, although a wide initial pulse 
pressure also tended to indicate that the terminal kidney 
weight would be low (see Table 12 ). A summary of the other 
regression results is provided in Tables 13 and 14. 
II. Application o f Discriminant Equation - Y a 1e-N ew Haven 
Hospital: 
A. Population: 
The entire population collected from Yale-New 
Haven Hospital consisted of 28 patients, all of whom suffered 
from primary hypertension. Of this population, 9 patients 
diedof renal failure and 19 died of other causes. Classifica¬ 
tion by race and sex is provided in Table 15. White females 
and Negro males constituted the larges segment (77.7%) of 
those patients ultimately dying of renal failure, while whites 

39 
both male and female, comprised the largest segment (84.2%) 
of those patients ultimately dying of other causes. 
B. Causes o f Death: 
The causes of death among those patients not dying 
of renal failure are listed in Table 16. Again, cerebro¬ 
vascular accidents were the most frequent cause of death 
though only 5 patients died from this. Four patients died 
of myocardial infarction, and pneumonia and pulmonary embolus 
each claimed 2 lives. 
Renal failure was the cause of death in 9 patients. 
Postmortem examination again revealed kidneys which were 
generally contracted and shrunken with granular appearance 
on gross inspection. Microscopic inspection revealed evidence 
of arteriolar nephrosclerosis in each case, but no evidence 
of fibrinoid necrosis. The mean weight of the kidneys of 
those dying of renal failure was 86 Grams as contrasted to 
131 Grams for those dying of other causes. 
C . Clinical Data: 
A summary of the clinical data used in the discrimi¬ 
nant equation for the group dying of renal failure and the 
group dying of other causes is presented in Table 17. The 
mean systolic blood pressure at the time the diagnosis of 
hypertension was first made was 212 mm Hg for those patients 
who ultimately died of renal failure and only 183 mm Hg for 

40 
those who eventually died of other causes. The average age 
at which the diagnosis of hypertension was first made was 
only 45 years for those dying of renal failure, but was 66 
years for those dying of other causes. The initial blood 
urea was 100 mg/100 ml for those dying of renal failure and 
35 mg/100 ml for those dying of other causes. The initial 
card!ac-thoracic ratio was 53% for patients dying of renal 
failure, and 51% for those dying of other causes. Finally, 
the average age at the time of death was 46 years among those 
dying of renal failure and 71 years among those dying of 
other causes. 
D. Pis criminant Scores an d Accuracy o f Prediction: 
The discriminant equation derived from the clinical 
data of the patients at the University of Virginia Hospital 
was then applied to the above mentioned clinical data obtained 
from the population of patients with primary hypertension at 
the Yale-New Haven Hospital. The discriminant scores cal¬ 
culated both for those patients dying of renal failure and 
those dying of other causes are listed in Table 18. The 
discriminant scores for those dying of renal failure ranged 
form 176.5 to 456.0 (mean, 297.6; S.D.= 89.9). The dis¬ 
criminant scores for those dying of other causes ranged from 
144.2 to 273.0 (mean, 181.4; S.D.= 27.7). 
Of the 9 patients who ultimately died of renal failure. 
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2 had discriminant scores less than 249 (176.5, 224.0) and 
would, therefore, have been predicted incorrectly to die of 
other causes. Of the 19 patients who ultimately died of 
causes other than renal failure, only 1 had a discriminant 
score greater than 249 (273.0) and would, therefore, have 
been predicted incorrectly to die of renal failure. The 
expected number of misc1 assifications (based on the 15% mis- 
observed in the population at the University 
of Virginia Hospital at the cutoff of 249) in the group dying 
of causes other than renal failure was 3. The expected number 
of misc1 assifications in the group dying of renal failure 
was 1. The false negative ratio for those predicted to die 
of renal failure was 2/9 or 22%, whereas the false positive 
ratio was 1/19 or 5.3% (see Table 19). Another manner of 
expressing the prognostic accuracy of the discriminant equation 
is depicted in Table 20. When the patients were ranked into 
tertiles of discriminant score, it was found that 8 of the 
9 patients in the lowest tertile died of other causes while 
all 10 of the patients in the middle tertile died of other 







I. Discussion o f Methods: 
The basic goal in choosing the populations, both for 
the study at the University of Virginia Hospital and at the 
Yale-New Haven Hospital, was to select those patients who 
suffered from primary hypertension and whose cause of death 
could be documented as accurately as possible. In order to 
avoid including any patient with a lesion capable of causing 
secondary hypertension, the post mortem record of each patient 
in the study had to be carefully reviewed. It is quite pos¬ 
sible, however, that the kidneys of a patient with either 
chronic g1omero1 onephritis or chronic pyelonephritis might 
be very difficult to distinguish from those of a patient 
with only primary hypertension and renal failure. Therefore, 
the clinical record of each patient was also carefully re¬ 
viewed to avoid including any patient in the study with a his¬ 
tory of inflammatory kidney disease. Nevertheless, it is 
still possible that a patient with chronic asymptomatic 
urinary tract infection would have escaped such scrutiny and 
have been included in the study. 
With regard to the measurement of the clinical variables 
which made up the parameters used in the discriminant analysis. 
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a few words are in order. While it is probably true that 
the cardiac-thoracic ratio is a rough and often inaccurate 
estimate of the presence of cardiac enlargement,^ it is a 
simpler, more reproducible measurement than many of the 
other methods available. Also, there appeared to be a 
rather good association between the cardiac-thoracic ratio 
and the degree of cardiac enlargement found at postmortem 
examination, since the renal failure group had both a 
significantly greater mean heart weight (p<T 0.001) and a 
significantly greater mean c a r d i a c - t h o r a c i c ratio (p<^'0.008) 
than did the comparison group. Nonetheless, it is true that 
regression analysis failed to demonstrate a very close fit 
between heart weight and initial cardiac-thoracic ratio 
(see Table 14). Similarly, the blood creatinine would have 
been a more specific and a more sensitive index of renal 
function than the blood urea,^ but the fact that the blood 
creatinine was initially measured in only 9 patients in the 
comparison group at the University of Virginia Hospital pre¬ 
cluded its use. Further, the blood urea did provide the 
greatest discrimination among the variables used in the dis¬ 
criminant equation (see Table 11). 
The majority of the blood pressures recorded in this 
study were taken only once during the initial examination, 
though multiple readings were averaged when they were recorded. 
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In the light of recent information suggesting that Negroes 
demonstrate a greater decline on subsequent readings of 
36 
blood pressure than do whites , it is possible that the 
mean blood pressures in this study, especially of Negroes, 
are biased toward higher values. 
With regard to the actual age at onset of hypertension, 
it is, of course, quite impossible to determine this with any 
great accuracy retrospectively. Hypertension is initially 
discovered either when it becomes symptomatic or fortuitously 
on physical examination. The term "age at onset" has been 
arbitrarily defined as the patient's age when the diagnosis 
of hypertension was initially made, and it is a necessary con¬ 
cept in this study to insure that the other clinical para¬ 
meters are all measured at a comparable time in each patient's 
course. This is not to say by any means that all of the 
patients presented for evaluation at the same stage in the 
course of their disease. The majority of the patients from 
both hospitals had their hypertension discovered when they 
became symptomatic and sought medical aid, but presumably both 
the threshold for, and the tolerance of, symptoms varies 
from one patient to another. Also, by choosing only those 
patients evaluated for the first time for hypertension at 
either hospital for inclusion into discriminant analysis, 
the effect of medical treatment on the parameters being 
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measured was excluded. Patients being hospitalized in the 
terminal stages of hypertensive cardiovascular disease were 
excluded, for the most part as well, by this method, for 
it would be of questionable validity to derive a means for 
predicting those patients destined to die of renal failure 
predominantly by analyzing patients already in florid uremia. 
What has been attempted, then, is to predict who such 
patients will be on the basis of their clinical findings at 
a time when their ultimate fate is not so apparent, and also 
at a time which is most useful in terms of mode of treatment - 
that is, when the disorder is first discovered by their 
physician. The major disadvantage of this requirement is ap¬ 
parent on examining Tables 1, 2, and 9. Out of a final total 
population of 174, only 110 (26 in the renal failure group 
and 84 in the comparison group - see "Age at Onset" in Table 
9) had their hypertension first diagnosed at the University 
of Virginia Hospital. Out of an initial total population 
of 358 patients, over 250 had a previous known history of 
hypertension in the study at the Yale-New Haven Hospital. 
A possible explanation for the greater number of patients with 
a known history of hypertension at the Yale-New Haven Hos¬ 
pital may be that, at least in the years studied, it served 
the function of primary physician to a smaller proportion 
of the population than did the University of Virginia Hospital, 

though this is only speculation. 
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The number of patients actually employed in deriving 
the discriminant equation was even smaller than the 110 
patients noted above because only 49 patients (14 in the 
renal failure group and 35 in the comparison group) had all 
of the data recorded for each clinical variable (see Table 11) 
Nonetheless, the differences between the variables of each 
group were very similar to those observed in the larger popu¬ 
lation (see Table 9), and the F ratio was clearly significant 
(p*£ 0.001). 
Finally it should be noted that this study, of necessity 
utilized information gathered from patients who were all 
hospitalized at least once in the course of their illness and 
who all died. The likelihood, therefore, that the population 
in this study is one of patients suffering from fairly severe 
hypertension is strong, a conclusion which is supported, more¬ 
over, by the mean blood pressures of all the groups in this 
population (see Tables 9, 10, and 17). Unfortunately, any 
study which relies on postmortem findings and hospital case 
records must suffer both from the problems of missing data 
and the bias of hospital selection. 
II. Discussion o f Results: 
A. Pathological and Clinical Findings: 
Given the relatively young age at onset of hyper- 

tension, the apparent severity, and the predominance of 
Negroes in the groups of patients dying of renal failure, 
the question naturally arises as to whether or not this 
simply represents a group of patients with malignant hyper¬ 
tension. Several important facts argue against such a 
conclusion, however. 
First, none of the patients in either the study at the 
University of Virginia Hopsital or at the Yale-New Haven Hos- 
9 10 
pital had a history of papilledema, * or evidence of 
10 
fibrinoid necrosis on renal section. Second, descriptions 
of kidneys removed during post mortem examination of patients 
with malignant hypertension have shown that these kidneys 
10 14 
vary from slightly below normal weight (130 Grams, 
9 
139 Grams ) to normal or slightly greater than normal 
2 1 
weight. In contrast, the kidneys from the group dying of 
renal failure at the University of Virginia Hospital were 
markedly contracted and decreased in weight (112 Grams, see 
Table 6). Third, cardiomegaly, while an extremely common 
finding in malignant hypertension, has rarely been recorded 
at the level observed in the renal failure group (607 Grams, 
8,9,13,14 
see Table 6). In fact, 79% of those patients dying 
of renal failure at the University of Virginia Hospital had 
hearts weighing 500 Grams or more (see Table 8). Kidney and 
heart weights were not specifically analyzed in the population 
selected from the Yale-New Haven Hospital since this popula¬ 
tion was chosen solely for application of the discriminant 
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equation. Fourth, the mean duration or survival time from 
the initial diagnosis of hypertension until death from renal 
failure in the University of Virginia Hospital group was 
5 years (see Table 9), in contrast to durations in malignant 
hypertension ranging generally from 1 month to 2 years.^ ’ 
Admittedly, the mean survival time was shorter for white pa¬ 
tients and for both white and Negro patients in the renal 
failure group at the Yale-New Haven Hospital, and the reason 
for this difference is not clear since in no case was there 
any evidence of papilledema or fibrinoid necrosis. Finally, 
the renal failure group from both hospitals had only a 
slight predominance of males over females which contrasts 
with the male predominance found in most studies of mal- 
9,13 
ignant hypertension and reported variously as 3:2, 
2 8 29 
2:1, an d greater. 
Despite all of these facts, the mean age at which the 
diagnosis of hypertension was made was 46 years in the renal 
failure group at the University of Virginia Hospital and 45 
years at the Yale-New Haven Hospital (see Tables 9 and 17). 
Further, more than 50% of the patients in this group for whom 
the diagnosis was made at the University of Virginia Hospital 
were less than 50 years old when the diagnosis was made, (see 
Table 7). This is very similar to the age at which malig¬ 
nant hypertension has been discovered, reported variously as 
8 21 10 
less than 50 years old, ’ between 40 and 50, between 33 
9 13 




39 to 4 7 . ^ ^ ^ , 1 7,2 8 The systolic blood nressure of the 
renal failure group at both hospitals was auite elevated 
at 212 mm Hg (see Tables 9 and 17), though still slightly 
less than the systolic levels most frequently reported in 
malignant hypertension which range from 220 mm Hg to 280 mm 
u 8,9,13,28 T . , , 
Hg. It is entirely possible, however, that by 
excluding patients with papilledema from either study, a 
population of patients in a premalignant phase of severe 
primary hypertension were selected. Since these patients 
all received medical therapy, usually quite vigorous, after 
the diagnosis was made, it is conceivable that this treatment 
prevented them from ever acquiring many of the usual char¬ 
acteristics of malignant hypertension. 
A precedent for this point of view is to be found in 
5 3 
the work of Dustan e t a1 who studied the effect of medical 
treatment on the course of malignant hypertension. Out of a 
total of 81 patients receiving vigorous medical therapy for 
malignant hypertension, they observed a 38% 7-year survival 
rate. Among these patients, the most common single cause of 
death was renal failure, accounting for 22 deaths. Interest¬ 
ingly enough, renal failure followed 2 different courses. 
The first was characterized by the rapidly progressive loss 
of renal function with death within 5 months to 1 year for 
9 patients. The second, however, was characterized by death 
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from slowly progressive renal failure for 13 patients. These 
patients survived from 14 to 60 months with a median sur¬ 
vival time of 27 months, and their excretory function stabilized 
for long periods of time, deteriorating only several months 
prior to death. Equally significant from the point of view 
of the present study was the fact that renal sections of these 
patients with slowly progressive renal failure who came to 
autopsy showed remission of all or most aspects of the necro¬ 
tizing arteriolar lesions of malignant hypertension, though 
the major branches of the renal artery, arcuate and inter¬ 
lobular, showed a diffuse fibrous intimal hyperplasia which 
54-5 7 
was sometimes occlusive. Increased survival time and 
remission of necrotizing arteriolar^ lesions have been 
reported in medically treated patients with malignant hyper¬ 
tension by other investigators, as well. Unfortunately, 
no mention was made of either the cardiac or renal weight of 
the patients in these studies. 
The group of renal failure patients at the University 
of Virginia Hospital were probably less severely ill than 
Dustan's group of patients with slowly progressive renal 
failure for none had papilledema and their mean survival 
time was longer. Their hypertension, however, was of a 
more severe form than their respective comparison group which 
lived longer and had lower levels of blood pressure (see 
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Table 9); it was virtually premalignant. The fact that 
their hearts were larger than those usually reported in mal¬ 
ignant hypertension might, in part, be explained by the fact 
that they lived much longer than most patients with untreated 
malignant hypertneion.^ 10,14 gut their hearts were even 
larger than those of the comparison group which had a longer 
mean survival time. One reason for this might be that their 
hypertension was more severe, but the regression analysis 
failed to support this view because it did not demonstrate 
a very close fit between initial systolic blood pressure 
and cardiac weight at death (see Table 14). 
Perhaps a more feasible explanation is that the renal 
failure group of patients had a greater fluid volume than did 
those patients dying of other causes, and this served as an 
additional stimulus for cardiac hypertrophy, since it has 
been shown that increased cardiac wall tension, as might be 
produced from the increasing radius of a dilating heart in 
a patient with excess fluid volume, will affect cardiac hy- 
5 8 
pertrophy. In fact, initial dilatation with subsequent 
hypertrophy would also explain why the renal failure group 
had a significantly greater cardiac-thoracic ratio (p< ' 0.008) 
than did the comparison group early in the course of their 
disease . 
A final explanation for the degree of cardiac hypertrophy 
observed in the renal failure group might well be that the 
status of their coronary circulation was better than that 
of the comparison group both because they were younger and 
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because patients with severe coronary artery disease who 
died of myocardial infarction were excluded from this 
group. To date, however, there have been no studies which 
document an actual association between coronary blood flow 
and myocardial hypertrophy, but it certainly seems reason¬ 
able that the increased metabolism of hypertrophy might 
require more nutrition from the vascular system. 
The markedly diminished weight of the kidneys of the 
renal failure group contrasted to those of patients with 
- . , . 9,10,14,21 . . , , . . 
malignant hypertension, again, could be explained 
by the prolonged course of their illness, though regression 
analysis failed to show a close fit between kidney weight and 
duration of hypertension (see Table 13). The reason for 
this may be that values for the entire population, both renal 
failure and comparison groups, were employed in the regression 
analysis. The comparison group, on the other hand, would be 
expected to have kidneys closer to normal weight simply because 
they were not afflicted with severe renal impairment. Inter¬ 
estingly, though, regression analysis did show a close asso¬ 
ciation between kidney weight and both initial systolic blood 
pressure and pulse pressure (see Table 12). 
As previously noted, the case group of patients dying 
of renal failure at the University of Virginia Hospital had 
a predominance of Negroes in it (26 Negroes and 10 whites in 
a hospital whose population is 45% Negro). At the Yale-New 
Haven Hospital there was only a slight predominence of Negroes 
in the renal failure group though the comparison group had 
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a much higher proportion of whites than Negroes (16 whites 
and 3 Negroes). All of this suggests that death from renal 
failure was more common among Negroes than whites in the pre¬ 
sent study. While the renal failure groups in both hospitals 
had a much higher systolic blood pressure than did the com¬ 
parison groups (see Tables 9 and 17), Negroes at the Univer¬ 
sity of Virginia Hospital dying of renal failure had somewhat 
lower systolic blood pressures than did whites. The clinical 
data obtained at the Yale-New Haven Hospital was not analyzed 
by race as the number of patients was smaller. Furthermore, 
in the comparison group and in the population as a whole at 
the University of Virginia Hospital, the blood pressure, both 
systolic and diastolic, of Negroes and whites were essentially 
identical. The findings, therefore, of investigators such as 
37 38 36 
McDonough, Comstock, and others that Negroes have higher 
blood pressures than whites were not consistent with those 
in this study, especially in view of the previously mentioned 
possibility of a bias toward slightly higher levels of blood 
pressure for Negroes in this study. 
In fact, despite the measurement of 16 clinical and 
pathological variables, significant (p-ec'0.05) racial differ¬ 
ences within each of the 2 groups from the University of Vir¬ 
ginia Hospital study were found in only 4 variables - heart 
weight, kidney weight, and cardiac-thoracic ratio in the 
comparison group and duration of the disease in the renal 

54 
failure group (see Tables 6 and 9). These small differences, 
however, cannot account for the much larger differences ob¬ 
served between the 2 groups. 
The relative predominance of Negroes dying of renal 
failure in the case groups from both hospitals does suggest, 
however, that there may be a racial difference in the suscept¬ 
ibility of the renal vascular bed to sclerosis. This in¬ 
creased susceptibility for Negroes could well be related to a 
relatively early onset of hypertension (see Table 9) destined 
to terminate in about 5 years in death from renal failure with 
severely contracted, shrunken kidneys. There are, of course, 
other possible explanations for this racial predominance. In 
particular, one might speculate that Negroes in this study 
had a greater prevalence than whites of chronic asymptomatic 
urinary tract infection from the outset with subsequent renal 
failure and secondary hypertension. It is impossible to 
refute such an hypothesis, though the preponderance of Negroes 
dying of renal failure makes it unlikely that this alone could 
explain the racial difference. 
The major racial differences among the causes of death 
in the comparison group at the University of Virginia Hospital 
were that a smaller percentage of Negro than white deaths 
were associated with aortic aneurysm or myocardial infarction, 
while a slightly higher percentage were associated with 
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cerebrovascular accidents (see Table 4). The number of Negro 
patients in the comparison group at the Yale-New Haven Hospital 
was too small to make any comment regarding racial differences 
(see Table 16). 
The entire comparison group at the University of Virginia 
Hospital, both Negroes and whites, had a greater percentage 
of deaths associated with cerebrovascular accidents than 
did either the series of treated hypertensive patients 
3 5 2 7 
reported by Smirk and Hodge or by Leishman, though the 
percentage of deaths associated with cerebrovascular accidents 
in the comparison group at the Yale-New Haven Hospital was 
essentially identical to the series of Smirk and Hodge. The 
percentage of deaths associated with myocardial infarction in 
both comparison groups in the present study was similar to 
34 
that reported by Hood e t a 1 in their series of treated 
hypertensive patients but lower than that reported by Smirk 
and Hodge. Death associated with congestive heart failure 
was infrequent in both the comparison groups in this study 
and in the series reported by Smirk and Hodge and Hood e t a 1. 
Differences and even similarities in causes of death 
between the comparison groups of the present study and those 
of other investigators are, of course, notoriously difficult 
to interpret. Processes of selection and modes of therapy 

both undoubtedly differ from one study to another. Since 
death was a primary requisite for inclusion into the present 
study, it is reasonable to assume that the patients in this 
study were on the average more severely ill than the patients 
in the aforementioned studies. In addition, since postmortem 
examination was also a requisite in the present study, it is 
likely that a greater proportion of lesions such as cerebro¬ 
vascular accident and myocardial infarction were discovered. 
Further, causes of death in the comparison groups in this 
study were occasionally multiple so it is difficult to compute 
case fatality rates accurately. In this context, then, it 
would be questionable at best to attempt to employ the finding 
of this study regarding cause of death in the comparison 
groups to either support or refute the findings of other 
investigators in this area. 
B. Discriminant Analysis: 
The value of the discriminant equation as a tool 
in the prognosis of disease has been admirably demonstrated 
48 
by Morris e_t_ a_l_ in their study of ischemic heart disease 
in London busmen. The present study demonstrates its useful¬ 
ness in predicting which patients with primary hypertension 
will ultimately die of renal failure on the basis of easily 
measured clinical parameters obtained rather early in the 
course of the disease. 

While the initial discriminant equation was derived from 
the analysis of only 49 patients out of the total population 
at the University of Virginia Hospital, the mean values of 
the clinical variables of these patients were quite represent¬ 
ative of the population as a whole (see Tables 9 and 11). 
Further, application of this equation onto the population from 
which it was derived revealed a misclassification rate of 
only 15% at scores below or above 249. To evaluate truly the 
accuracy of this prognostic tool, however, it was necessary 
to apply the equation onto a new population of patients. 
The mean values of the clinical variables of the popu¬ 
lation at the Yale- New Haven Hospital on which the discriminant 
equation was applied, except for somewhat smaller cardiac- 
thoracic ratios in both case and comparison groups and an older 
age at onset for the comparison group, were very similar to 
those at the University of Virginia Hospital (see Tables 11 
and 17). Discriminant analysis of this population revealed 
a very good separation of discriminant scores with little over¬ 
lap. The mean value of the discriminant score for the group 
dying of renal failure was 297.6 - 89.9, while for the 
comparison group, it was 181.4 - 27.7 (see Table 18). Indeed, 
if the discriminant scores are grouped by tertiles it can be 
seen that 18 of the 19 patients (95%) who ultimately died of 
causes other than renal failure fell into the lower two- 
thirds of the discriminant scores, while only 1 of the 9 
patients (11%) who ultimately died of renal failure fell into 
the lower two-thirds. 
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On the other hand, 8 of the 9 patients (89%) who ultimately 
died of renal failure fell into the upper one-third of 
discriminant scores, while only 1 of the 19 patients (5%) 
who ultimately died of causes other than renal failure 
fell into this one-third (see Table 20). Another possible 
manner of viewing these results is presented in Table 19. 
Using the cutoff point of 249 derived from the study at the 
University of Virginia Hospital, a false negative ratio of 
22% and a false positive ratio of 5% were obtained. 
To demonstrate the usefulness of the discriminant equa¬ 
tion, a typical patient has been selected from the case group 
and the comparison group for sample calculations: 
Case No. 7 is that of a Negro male who was 
diagnosed as hypertensive when he was 45 
years old. At this time, his systolic blood 
pressure was 225 mm Hg. A chest film revealed 
a cardiac-thoracic ratio 57%, and his blood 
urea was found to be 48.3 mg/100 ml. There¬ 
fore, D= -1.5 (45) + 3 (57) + 0.5 (225) 
+ 1 (48.3) = 264.3. Since D is greater than 
249, the prediction is that he would die of 
renal failure, which he did at age 48. 
Case No. 14 is that of a white male who was 
diagnosed as hypertensive at the age of 59. 
His systolic blood pressure was 170 mm Hg, his 
cardiac-thoracic ratio was 50%, and his blood 
urea was 33.3 mg/lOOml. Therefore, D = -1.5 
(59) + 3 (50) + 0.5 (170) + 1 (33.3) = 179.8. 
Since D is less than 249, the prediction is that 
he would die of some cause other than renal 
failure. The cause of death was a massive 
cerebral hemorrhage at age 67. 

In conclusion, then, it would seem from the present 
study that the individual with severe primary hypertension 
who is likely to die of renal failure presents to the 
clinician initially as a man or woman of either race, though 
most probably a Negro, about 45 or 46 years old, with a 
high blood pressure, especially systolic, fairly marked car¬ 
diac enlargement, and an elevated blood urea. Such a person 
may be suffering from premalignant hypertension and, if 
untreated, might go on to develop papilledema and expire with 
a year’s time. When treated vigorously, survival may be 
prolonged for several years with death ultimately coming in 
the form of renal failure accompanied by extreme cardiomegaly 






In a study of 174 patients who died with severe primary 
hypertension, it was found that those patients dying of renal 
failure could be identified with reasonable accuracy on the 
basis of the initial measurement of the systolic blood pres¬ 
sure, the cardiac-thoracic ratio, the blood urea, and the age 
of the patient at the time when the diagnosis of hypertension 
was first made. Such patients had higher initial systolic 
blood pressures and blood ureas, greater cardiac-thoracic 
ratios, and were of a younger age when the diagnosis of hyper¬ 
tension was initially made than were those patients with 
severe primary hypertension who died of other causes. The 
patients dying of renal failure also had a shorter survival 
time, a much greater degree of cardiomegaly, and more markedly 
contracted kidneys than did those dying of other causes. 
When the initial clinical observations were substituted 
in the discriminant equation: D = -1.5 (age at onset) + 3 
( cardiac-thoracic ratio) + 0.5 (systolic blood pressure) 
4- 1 (blood urea), it was found that 85% of the patients with 
a discriminant score (D) greater than 249 died of renal 
failure while 85% of the patients with a discriminant score 

6 1 
less than 249 died of other causes. This discriminant 
equation was then applied to a second population consisting 
of 28 patients who died with severe primary hypertension to 
determine its prognostic accuracy. A false negative ratio 
of 22% and a false positive ratio of 5% were obtained in 
this second population using 249 as the cutoff point for the 
discriminant scores. Further, when the patients in this 
second population were grouped by tertiles of their dis¬ 
criminant scores, 89% of the patients who died of renal fail¬ 
ure fell into the upper one-third of discriminant scores 
while 95% of the patients who died of causes other than renal 
failure fell into the lower two-thirds of the discriminant 
scores. 
While no convincing evidence was found that the 
natural history of primary hypertension varied between the 
white and Negro races, a majority of all those patients 
dying of renal failure were Negroes. It is suggested that 
the susceptibility to sclerosis of the renal vascular bed 
may be greater for Negroes than for whites. It is also 
postulated that the population dying of renal failure in this 
study may have been suffering from a form of premalignant 
hypertension when first evaluated and their survival time 
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T able 1 . Selection of Comparison and Case Groups from the 
Population at the University of Virginia Hospital. 
Comparison Group 
1. Patients with a clinical 
diagnosis of primary 
hypertension on 
portmortem records 250 
but of these 
a. patients having 
in f1amma t o ry 
kidney diseases 7 
b. patients with 
lost or 
in comple te 
records 85 
2 . Remaining: 
patients with post¬ 
mortem and clinical 
records consistent 
with the diagnosis 
of primary hyper¬ 
tension 158 
Case Group 
1. Patients with a clinical 
diagnosis of uremia on 
postmortem records 
butofthese 20 
a. patients without a 
history of primary 
hypertension in 
clinical records 4 
2. Remaining: 
patients with clinical 
and postmortem records 
consistent with the 
diagnosis of primary 
hypertension who died 
of renal failure 16 
plus 20 (see 2a in 
opposite column) 
(Case G roup) 3 6 
a. those patients 
dying of renal 
failure 20 
b . thos e patients 
dying of other 
caus es 
(Comp aris on Group) 138 
Final Total Population (Comp aris on and Case Groups) 
174 patients 

Table 2. Selection of Comparison and Case Groups from the 
Population at the Yale-New Haven Hospital. 
Comp aris on Group 
1. Patients with a clinical 
diagnosis of primary 
hypertension 300 
but of these 
a. patients with a 
his tory of 
hypertension prior 
to evaluation at 
this hospital 248 
b. patients for whom 
chest x-rays were 
un avai1ab 1 e 12 
c. patients for whom 
chest x-rays were not 
taken 6 
d. patients for whom blood 
urea levels were not 
drawn 6 
e. patients whose post¬ 
mortem records were 
unavailable 4 
2. Remaining: patients with 
primary hypertension first 
diagnosed at this hospital 
with all necessary clinical 
data available 24 
a. those patients dying 
of renal failure 5 
b. those patients dying 
of other causes 
(Comparison Group) 19 
Final Total Population 
2 8 
1. Patients with a clinical 
diagnosis of uremia 
but of these 
a. patients without a 
previous history 
of hypertension 14 
b. patients with either 
a history of hyper¬ 
tension prior to 
evaluation at this 
hospital or a 
history of inflam- 
ma tory kidney 
diseases 36 
c. patients for whom 
chest x-rays were 
un available 2 
d. patients whose post¬ 
mortem records were 
un avai1able 2 
2. Remaining: patients 
dying of renal failure 
with a clinical history 
of primary hypertension 
first diagnosed at this 
hospital with all 
necessary clinical data 
avai1ab1e 4 
plus 5 (see 2a in 
opposite column) 
(Case Group) 9 
(Comparison and Case Groups) 
patients 

Table 3. Characteristics of the Hypertensive Population 
at the University of Virginia Hospital - Those 
who died from Renal Failure (36) and Those who 
died from other Causes (138). 
Race Sex Death from 




Male 7 48 
F e ma1e 3 26 
Negro 
Male 13 31 
F e ma1e 13 33 

Table 4. Causes of Death among the 138 Patients of the 
Comparison Group at the University of 
Virginia Hospital.* 
Total Race 
Causes of Death No . % Wh i t e Negro 
Cerebrovascular Accident 73 52.9 36 3 7 
cerebral hemorrhage 53 26 27 
cerebral infarction 20 10 10 
Myocardial Infarction 29 21.0 20 9 
Congestive Heart Failure 16 11.6 8 8 
Diabetes Mellitus 16 11.6 6 10 
Aortic Aneurysm 13 9 . 4 11 2 
Pulmonary Embolus 4 2 . 9 2 2 
C an ce r 4 2 . 9 3 1 
Sep ticemia 3 2 . 2 1 2 
Cardiac Arrhythmia 3 2 . 2 2 1 
Mesenteric Artery Thrombosis 2 1.4 1 1 
Other 12 8 . 7 
Other includes one case each of ruptured berry aneurysm, 
pancreatitis, splenic infarction, terminal renal infarction, 
aspiration, pneumonia, brain abscess, myocardial fibrosis, 
asthma, ulcerative colitis, meningitis, and pulmonary artery 
thro mb o sis. 
* In several cases, multiple causes of death were recorded 
for this comparison group so that the total number of 
causes of death is greater than 138 and the total percentage 
is greater than 100%. 

Table 5. Associated Conditions among the 36 Patients 
dying of Renal Failure at the University of 
Virginia Hospital. 
Associated Conditions Total Race 
No . % Wh i t e Negro 
Diabetes Mellitus 7 19.4 1 6 
Congestive Heart Failure 7 19.4 2 5 
Pne umonia 2 5.5 1 1 
G.I. Bleeding 1 2 . 8 0 1 
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Table 8. Analysis of Heart Weight of the Entire 
Population at the University of Virginia 
Hospital. 
Heart Weight (Gms.) 
Death from Renal 
Failure ( s . s . 34) 
Death from Other 
Causes (s.s.13 8) 
200-299 0 4 
300-399 2 29 
400-499 5 34 
500-599 12 34 
600-699 5 19 
700-799 7 13 
800-899 2 4 
900-999 1 1 
+ + 
Mean Wt. (Gms.) 607.1 - 136.4 503.2 - 1 37.3 
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Table 12. Regression Analyses of Kidney Weight Versus Other 
Initial Clinical Variables in 101 Cases of 
Primary Hypertension at the University of 
Virginia Hospital. 
Regression Equation: Kidney Weight = a + b (variable). 






Coefficient (b) -0.435 -0.480 
Weight Intercept (a) 2 17.3 174.5 
Significance 
F1 ,99 Ratio 12.25 8.56 
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Table 15. Characteristics of the Hypertensive Population 
at the Yale-New Haven Hospital - Those who 
died from Renal Failure (9) and Those who died 
from Other Causes (19). 
lace Sex 
Death f rom 
Renal Failure 
Death f rom 
Other Causes 
/tfh i t e Ma le 1 9 
Female 3 7 
^e g r o Ma le 4 2 
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Table 18. Discriminant Scores and Means and Standard 
Deviations for those Dying of Renal Failure 
and those Dying of Other Causes at the 
Yale-New Haven Hospital. 
DISCRIMINANT SCORES 
Dying of Renal Failure (9 cases) Dying of Other Causes (19 cases) 




(2) (2) 156.5 
(3) 249.9 (3) 158.8 
(4) 251.2 (4) 161.3 
(5) 264.3 (5) 164. 1 
(6) 301.4 (6) 165 . 3 
(7) 354.5 (7) 169 . 4 
(8) 401.0 (8) 170.7 
(9) 456.0 (9) 177.1 
(10) 177.3 
D.- 89.9 
(ID 17 7.6 
Mean 297.6 S. (12) 179.8 
(13) 185.4 
(14) 188.3 




(19) 2 7 3.0 
Mean 181 .4 S.D.- 27.7 
Denotes that cases would be misc1 assified according to the 
following criterion: classify the subject as "dying of 
renal failure" if D ^249, and classify the subject as 
"dying of other causes" if D 2 4 9 . 

Table 19. False Negative and False Positive Ratios 
for Discriminant Function Analysis of the 
Population at the Yale-New Haven Hospital. 
Dying of Dying of 
Renal Failure Other Causes 
Actually 
Observed 9 19 
Correctly 
Predicted 7 18 



































Table 20. Analysis of Those Dying of Renal Failure 
and Those Dying of Other Causes at the 
Yale-New Haven Hospital by Tertiles of 
Discriminant Score. 
Dying of Dying of 
Renal Failure Other Causes 
0 0 0 0 
0 0 0 0 1 8 
0 
0 0 0 0 
0 0 0 0 0 10 
0 0 
0 0 0 0 
0 0 0 0 8 1 
0 
Total 9 19 
• Patients dying of renal failure 
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